Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

March 01, 2011; Volume 39,Issue 3

Articles

  • You have access
    Measurement of Unbound Drug Exposure in Brain: Modeling of pH Partitioning Explains Diverging Results between the Brain Slice and Brain Homogenate Methods
    Markus Fridén, Fredrik Bergström, Hong Wan, Mikael Rehngren, Gustav Ahlin, Margareta Hammarlund-Udenaes and Ulf Bredberg
    Drug Metabolism and Disposition March 2011, 39 (3) 353-362; DOI: https://doi.org/10.1124/dmd.110.035998
  • You have access
    Casopitant: In Vitro Data and SimCyp Simulation to Predict In Vivo Metabolic Interactions Involving Cytochrome P450 3A4
    Paola Motta, Nicoletta Pons, Sabrina Pagliarusco, Mario Pellegatti and Fiorenza Bonomo
    Drug Metabolism and Disposition March 2011, 39 (3) 363-372; DOI: https://doi.org/10.1124/dmd.110.035071
  • You have access
    Utility of Intersystem Extrapolation Factors in Early Reaction Phenotyping and the Quantitative Extrapolation of Human Liver Microsomal Intrinsic Clearance Using Recombinant Cytochromes P450
    Yuan Chen, Liling Liu, Khanh Nguyen and Adrian J. Fretland
    Drug Metabolism and Disposition March 2011, 39 (3) 373-382; DOI: https://doi.org/10.1124/dmd.110.035147
  • You have access
    Prediction of Oral Pharmacokinetics of cMet Kinase Inhibitors in Humans: Physiologically Based Pharmacokinetic Model Versus Traditional One-Compartment Model
    Shinji Yamazaki, Judith Skaptason, David Romero, Sylvia Vekich, Hannah M. Jones, Weiwei Tan, Keith D. Wilner and Tatiana Koudriakova
    Drug Metabolism and Disposition March 2011, 39 (3) 383-393; DOI: https://doi.org/10.1124/dmd.110.035857
  • You have access
    CYP3A-Mediated Generation of Aldehyde and Hydrazine in Atazanavir Metabolism
    Feng Li, Jie Lu, Laiyou Wang and Xiaochao Ma
    Drug Metabolism and Disposition March 2011, 39 (3) 394-401; DOI: https://doi.org/10.1124/dmd.110.036327
  • You have access
    Pharmacokinetic and Pharmacodynamic Properties of Cholinesterase Inhibitors Donepezil, Tacrine, and Galantamine in Aged and Young Lister Hooded Rats
    Catherine W. Goh, Chiu Cheong Aw, Jasinda H. Lee, Christopher P. Chen and Edward R. Browne
    Drug Metabolism and Disposition March 2011, 39 (3) 402-411; DOI: https://doi.org/10.1124/dmd.110.035964
  • You have access
    Simple, Direct, and Informative Method for the Assessment of CYP2C19 Enzyme Inactivation Kinetics
    Kaisa A. Salminen, Jukka Leppänen, Jarkko I. Venäläinen, Markku Pasanen, Seppo Auriola, Risto O. Juvonen and Hannu Raunio
    Drug Metabolism and Disposition March 2011, 39 (3) 412-418; DOI: https://doi.org/10.1124/dmd.110.036376
  • You have access
    Opposite Effect of Diabetes Mellitus Induced by Streptozotocin on Oral and Intravenous Pharmacokinetics of Verapamil in Rats
    Nan Hu, Shanshan Xie, Li Liu, Xinting Wang, Xian Pan, Guanming Chen, Lulu Zhang, Haiyan Liu, Xiang Liu, Xiaodong Liu, Lin Xie and Guangji Wang
    Drug Metabolism and Disposition March 2011, 39 (3) 419-425; DOI: https://doi.org/10.1124/dmd.110.035642
  • You have access
    The Bioflavonoid Kaempferol Is an Abcg2 Substrate and Inhibits Abcg2-Mediated Quercetin Efflux
    Guohua An, Jorge Gallegos and Marilyn E. Morris
    Drug Metabolism and Disposition March 2011, 39 (3) 426-432; DOI: https://doi.org/10.1124/dmd.110.035212
  • You have access
    Validation of Isolated Metabolites from Drug Metabolism Studies as Analytical Standards by Quantitative NMR
    Gregory S. Walker, Tim F. Ryder, Raman Sharma, Evan B. Smith and Amy Freund
    Drug Metabolism and Disposition March 2011, 39 (3) 433-440; DOI: https://doi.org/10.1124/dmd.110.036343
  • You have access
    Decreased Hepatic Breast Cancer Resistance Protein Expression and Function in Multidrug Resistance-Associated Protein 2-Deficient (TR−) Rats
    Wei Yue, Jin Kyung Lee, Koji Abe, Yuichi Sugiyama and Kim L. R. Brouwer
    Drug Metabolism and Disposition March 2011, 39 (3) 441-447; DOI: https://doi.org/10.1124/dmd.110.035188
  • You have access
    Diabetes Mellitus Reduces Activity of Human UDP-Glucuronosyltransferase 2B7 in Liver and Kidney Leading to Decreased Formation of Mycophenolic Acid Acyl-Glucuronide Metabolite
    Miroslav Dostalek, Michael H. Court, Suwagmani Hazarika and Fatemeh Akhlaghi
    Drug Metabolism and Disposition March 2011, 39 (3) 448-455; DOI: https://doi.org/10.1124/dmd.110.036608
  • You have access
    Effects of Cell Differentiation and Assay Conditions on the UDP-Glucuronosyltransferase Activity in Caco-2 Cells
    Hongbo Zhang, Ari Tolonen, Timo Rousu, Jouni Hirvonen and Moshe Finel
    Drug Metabolism and Disposition March 2011, 39 (3) 456-464; DOI: https://doi.org/10.1124/dmd.110.036582
  • You have access
    Gestational and Pregnane X Receptor-Mediated Regulation of Placental ATP-Binding Cassette Drug Transporters in Mice
    Sarabjit S. Gahir and Micheline Piquette-Miller
    Drug Metabolism and Disposition March 2011, 39 (3) 465-471; DOI: https://doi.org/10.1124/dmd.110.034983
  • You have access
    Identification of 20(S)-Protopanaxadiol Metabolites in Human Liver Microsomes and Human Hepatocytes
    Liang Li, Xiaoyan Chen, Dan Li and Dafang Zhong
    Drug Metabolism and Disposition March 2011, 39 (3) 472-483; DOI: https://doi.org/10.1124/dmd.110.036723
  • You have access
    Repeated Injection of High Doses of Hemoglobin-Encapsulated Liposomes (Hemoglobin Vesicles) Induces Accelerated Blood Clearance in a Hemorrhagic Shock Rat Model
    Kazuaki Taguchi, Yasunori Iwao, Hiroshi Watanabe, Daisuke Kadowaki, Hiromi Sakai, Koichi Kobayashi, Hirohisa Horinouchi, Toru Maruyama and Masaki Otagiri
    Drug Metabolism and Disposition March 2011, 39 (3) 484-489; DOI: https://doi.org/10.1124/dmd.110.036913
  • You have access
    Hepatocyte Nuclear Factor 4α Regulates Expression of the Mouse Female-Specific Cyp3a41 Gene in the Liver
    Wattanaporn Bhadhprasit, Tsutomu Sakuma, Yuki Kawasaki and Nobuo Nemoto
    Drug Metabolism and Disposition March 2011, 39 (3) 490-497; DOI: https://doi.org/10.1124/dmd.110.035980
  • You have access
    Disposition and Metabolism of Cumene in F344 Rats and B6C3F1 Mice
    Ling-Jen Chen, Christopher J. Wegerski, Daniel J. Kramer, Leslie A. Thomas, Jacob D. McDonald, Kelly J. Dix and J. Michael Sanders
    Drug Metabolism and Disposition March 2011, 39 (3) 498-509; DOI: https://doi.org/10.1124/dmd.110.034769
  • You have access
    Characterization of Human Liver Enzymes Involved in the Biotransformation of Boceprevir, a Hepatitis C Virus Protease Inhibitor
    Anima Ghosal, Yuan Yuan, Wei Tong, Ai-Duen Su, Chunyan Gu, Swapan K. Chowdhury, Narendra S. Kishnani and Kevin B. Alton
    Drug Metabolism and Disposition March 2011, 39 (3) 510-521; DOI: https://doi.org/10.1124/dmd.110.036996
  • You have access
    Atazanavir Metabolism According to CYP3A5 Status: An In Vitro-In Vivo Assessment
    Michael F. Wempe and Peter L. Anderson
    Drug Metabolism and Disposition March 2011, 39 (3) 522-527; DOI: https://doi.org/10.1124/dmd.110.036178
  • You have access
    Similarities and Differences in the Expression of Drug-Metabolizing Enzymes between Human Hepatic Cell Lines and Primary Human Hepatocytes
    Lei Guo, Stacey Dial, Leming Shi, William Branham, Jie Liu, Jia-Long Fang, Bridgett Green, Helen Deng, Jim Kaput and Baitang Ning
    Drug Metabolism and Disposition March 2011, 39 (3) 528-538; DOI: https://doi.org/10.1124/dmd.110.035873
  • You have access
    Comparison of In Vitro Metabolism of Ticlopidine by Human Cytochrome P450 2B6 and Rabbit Cytochrome P450 2B4
    Jyothi C. Talakad, Manish B. Shah, Gregory S. Walker, Cathie Xiang, James R. Halpert and Deepak Dalvie
    Drug Metabolism and Disposition March 2011, 39 (3) 539-550; DOI: https://doi.org/10.1124/dmd.110.037101
  • You have access
    Control and Measurement of Plasma pH in Equilibrium Dialysis: Influence on Drug Plasma Protein Binding
    Ruth E. Curran, Christopher R. J. Claxton, Laura Hutchison, Paul J. Harradine, Iain J. Martin and Peter Littlewood
    Drug Metabolism and Disposition March 2011, 39 (3) 551-557; DOI: https://doi.org/10.1124/dmd.110.036988

Accelerated Communication

  • You have access
    Endoxifen, the Active Metabolite of Tamoxifen, Is a Substrate of the Efflux Transporter P-Glycoprotein (Multidrug Resistance 1)
    Wendy A. Teft, Sara E. Mansell and Richard B. Kim
    Drug Metabolism and Disposition March 2011, 39 (3) 558-562; DOI: https://doi.org/10.1124/dmd.110.036160

Erratum

  • You have access
    CORRECTION TO “Influence of Cremophor EL and Genetic Polymorphisms on the Pharmacokinetics of Paclitaxel and Its Metabolites Using a Mechanism-Based Model”
    Drug Metabolism and Disposition March 2011, 39 (3) 563; DOI: https://doi.org/10.1124/dmd.39.3.563
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 39 (3)
Drug Metabolism and Disposition
Vol. 39, Issue 3
1 Mar 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Articles
  • Accelerated Communication
  • Erratum
  • Most Read
Loading
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Switch from CAR to PXR in the Presence of EGF
  • Alternative P450 Splicing Redirects Human Drug Metabolism
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics